Literature DB >> 3545487

Intracellular calcium and smooth muscle contraction.

L E Sommerville, D J Hartshorne.   

Abstract

Excitation-contraction coupling in smooth muscle involves many processes, some of which are outlined in this article. The total amount of Ca2+ released on excitation is considerably in excess of the free Ca2+ concentration and this implies a high capacity, high affinity Ca2+ buffer system. The two major Ca2+-binding proteins are calmodulin and myosin. Only calmodulin has the appropriate binding affinity to act as a component of the Ca2+-buffer system. The Ca2+-calmodulin complex activates myosin light chain kinase and thus is involved in the regulation of contractile activity. Phosphorylation of myosin stabilizes an active conformation and promotes cross bridge cycling and is essential for the initiation of contraction. During the initial contractile response phosphorylation correlates to tension development and velocity of shortening. However, as contraction continues the extent of myosin phosphorylation and velocity often decreases but tension is maintained. In general, the Ca2+ transient is reflected by the extent of phosphorylation that in turn correlates with shortening velocity. Maintenance of tension at low phosphorylation levels is not accounted for within our understanding of the phosphorylation theory and thus alternative regulatory mechanisms have been implicated. Some of the possibilities are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3545487     DOI: 10.1016/0143-4160(86)90038-2

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  11 in total

1.  Involvement of caldesmon at the actin-myosin interface.

Authors:  M C Harricane; E Fabbrizio; C Arpin; D Mornet
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

2.  Potentiation of vascular smooth muscle cell activity by cyclosporin A.

Authors:  R Locher; R Huss; W Vetter
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  The role of intracellular calcium stores in motilin induced contractions of the longitudinal muscle of the rabbit duodenum.

Authors:  G Matthijs; T L Peeters; G Vantrappen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-03       Impact factor: 3.000

4.  Effects of diltiazem on calcium concentrations in the cytosol and on force of contractions in porcine coronary arterial strips.

Authors:  K Hirano; H Kanaide; S Abe; M Nakamura
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

5.  Temporal changes in the calcium-force relation during histamine-induced contractions of strips of the coronary artery of the pig.

Authors:  K Hirano; H Kanaide; S Abe; M Nakamura
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

6.  Front-surface fluorometry with fura-2 and effects of nitroglycerin on cytosolic calcium concentrations and on tension in the coronary artery of the pig.

Authors:  S Abe; H Kanaide; M Nakamura
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

7.  Down-regulation of protein kinase C potentiates angiotensin II-stimulated polyphosphoinositide hydrolysis in vascular smooth-muscle cells.

Authors:  J Pfeilschifter; M Ochsner; S Whitebread; M De Gasparo
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

8.  The effect of relaxants working through different transduction mechanisms on the tonic contraction produced in rat aorta by 4 beta-phorbol dibutyrate.

Authors:  A W Obianime; M M Dale
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

9.  The effect of Nicorandil on chronic cerebral vasospasm.

Authors:  T Matsui; T Nagafuji; K Tsutsumi; H Uchida; T Miyauchi; T Asano
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

10.  Cyclosporin A augments angiotensin II-stimulated rise in intracellular free calcium in vascular smooth muscle cells.

Authors:  J Pfeilschifter; U T Rüegg
Journal:  Biochem J       Date:  1987-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.